Arrhythmias & electrophysiology

Clinical and genetic variant re-analysis among pediatric probands undergoing genetic testing for arrhythmia syndromes

Heart RhythmPublished Retrospective cohort study

Authors' conclusion

Variant reclassification led to changes in 23% of probands, both downgrading and upgrading status, even among probands initially thought to be pathogenic. When comparing later to earlier eras, VUS variants increased while diagnostic yield decreased.

Study context

Population
Probands <18 years undergoing genetic testing for suspected inherited cardiac conditions associated with arrhythmias, 2007 to 2018
Participants
306 probands
Exposure
Early era vs later era; higher vs lower clinical disease likelihood
Outcome
Longitudinal changes in diagnostic yield and variant classification (reclassification in October 2023 using VarSome and ACMG criteria)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Diagnostic yield and variant classification
Initial testing diagnostic
23.2%
Initial testing non-diagnostic (33.7% no variant, 21.9% B/LB)
55.6%
Initial testing variants of uncertain significance (VUS)
21.2%
Diagnostic yield decreased, early vs later era
34.1%-15.3%
VUS increased, early vs later era
9.3%-29.9%
Non-diagnostic remained similar, early vs later era
55% to 57%
Probands with ≥1 variant whose variants changed on reclassification (46/203)
22.7%
Diagnostic variants downgraded to VUS or non-diagnostic (7/71)
9.9%
VUS changed (23.1% upgraded, 36.9% downgraded)
60.0%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
Diagnostic result, higher vs lower clinical disease likelihood, regardless of era6.3 (3.2–12.4)P < 0.0001

Original publication

Clinical and genetic variant re-analysis among pediatric probands undergoing genetic testing for arrhythmia syndromes. Heart Rhythm. Published 16 May 2025. doi:10.1016/j.hrthm.2025.05.016

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.